59 related articles for article (PubMed ID: 2942495)
21. Long-term treatment of bronchial asthma with pirbuterol aerosol.
Beumer HM
Int J Clin Pharmacol Ther Toxicol; 1983 Apr; 21(4):172-5. PubMed ID: 6862719
[TBL] [Abstract][Full Text] [Related]
22. Acute bronchial and cardiovascular effects of increasing doses of pirbuterol acetate aerosol in asthma.
Littner MR; Tashkin DP; Calvarese B; Bautista M
Ann Allergy; 1982 Jan; 48(1):14-20. PubMed ID: 7055342
[No Abstract] [Full Text] [Related]
23. [Bronchodilating effects of procaterol and aminophylline alone and in combination in asthmatic patients].
Tsukioka K
Nihon Kyobu Shikkan Gakkai Zasshi; 1985 Nov; 23(11):1301-7. PubMed ID: 2936913
[No Abstract] [Full Text] [Related]
24. [Methods of detection and treatment of bronchial hyperreactivity].
Zellweger JP
Schweiz Med Wochenschr; 1983 Jul; 113(29):1014-8. PubMed ID: 6612280
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of exercise-induced asthma by oral procaterol, a new beta 2-adrenergic drug.
Del Bufalo C; Fasano L; Gunella G
Respiration; 1984; 46(1):114-20. PubMed ID: 6238381
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of a new B 2 adrenergic receptor stimulant, terbutaline, in bronchial asthma. II. Oral comparison with ephedrine.
Dulfano MJ; Glass P
Curr Ther Res Clin Exp; 1973 Apr; 15(4):150-7. PubMed ID: 4144567
[No Abstract] [Full Text] [Related]
27. Prevention of bronchial hyperreactivity in atopic asthmatics during the period of maximal allergenic risk: a six-month study.
Dal Negro RW; Turco P; Zoccatelli O; Trevisan F; Pomari C
Int J Clin Pharmacol Ther Toxicol; 1986 Feb; 24(2):100-3. PubMed ID: 3957492
[TBL] [Abstract][Full Text] [Related]
28. Risk of acute bronchospasm and bronchial hyperreactivity from inhaled acid aerosol in healthy subjects: randomized, double-blind controlled trial.
Mirić M; Plavec D
Croat Med J; 2004 Dec; 45(6):709-14. PubMed ID: 15578804
[TBL] [Abstract][Full Text] [Related]
29. [Validity of the test of specific bronchial provocation evaluated in biological unit].
Mazzarella G; Cammarata A; Grella E; Signoriello G; Marzo C
Arch Monaldi Mal Torace; 1987; 42(4):345-54. PubMed ID: 3155414
[No Abstract] [Full Text] [Related]
30. [Prevalence of bronchial hyperreactivity in a healthy adult population. Preliminary results of a survey].
Zellweger JP; Leuenberger P; Mocostabella P
Schweiz Med Wochenschr; 1985 Sep; 115(39):1368-70. PubMed ID: 3906876
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. I: Bronchodilating effect.
Murai T; Maejima T; Sanai K; Osada E
Arzneimittelforschung; 1984; 34(11A):1633-40. PubMed ID: 6152156
[TBL] [Abstract][Full Text] [Related]
32. [Bronchial hyperreactivity. Irritant agents. Technics of stimulation and functional exploration].
Grella E; Cammarata A; Liccardo G; Mazzarella G
Arch Monaldi Mal Torace; 1988; 43(1):43-70. PubMed ID: 3073716
[No Abstract] [Full Text] [Related]
33. [Comparative effects of a new beta-adrenergic stimulant in asthma].
Gayrard P; Orehek J; Charpin J
Presse Med (1893); 1970 Dec; 78(52):2337-8. PubMed ID: 4395151
[No Abstract] [Full Text] [Related]
34. Bronchodilating drugs and airway reactivity.
Guerrin F; Robin H; Lahoutte C; Voisin C
Eur J Respir Dis Suppl; 1980; 106():71-5. PubMed ID: 6110561
[TBL] [Abstract][Full Text] [Related]
35. [The effect of salmeterol on the number of hypodense eosinophils, eosinophilic cationic protein levels ECP in serum, bronchial hyperresponsiveness and lung function test in patients with bronchial asthma].
Chazan R; Grubek-Jaworska H; Hermanowicz-Salomon J; Droszcz W
Pol Merkur Lekarski; 1997 Oct; 3(16):180-2. PubMed ID: 9461726
[TBL] [Abstract][Full Text] [Related]
36. [Acute effect of inhaled beta(2)-agonists with different type of intrinsic activity on airway resistance in healthy volunteers].
Kishimoto N; Ohnishi H; Fujita J; Kamei T; Tada S; Ueda N
Arerugi; 2004 Apr; 53(4):417-22. PubMed ID: 15187486
[TBL] [Abstract][Full Text] [Related]
37. [Respiratory allergies in the child and the adult].
Magnan A
Rev Prat; 2004 Jan; 54(2):189-98. PubMed ID: 15086062
[No Abstract] [Full Text] [Related]
38. The physical properties of a jet-nebulizer and their relevance for the histamine provocation test.
Sterk PJ; Plomp A; Crobach MJ; van de Vate JF; Quanjer PH
Bull Eur Physiopathol Respir; 1983; 19(1):27-36. PubMed ID: 6850144
[TBL] [Abstract][Full Text] [Related]
39. [How does the patient use his bronchodilating dose-aerosol?].
Arvastson B; Björkander J; Eklundh G; Korsgaard R; Pelkin S; Riebe I; Simonsson BG; Stiksa G; Werner S
Lakartidningen; 1976 Apr; 73(15):1407-9. PubMed ID: 1263658
[No Abstract] [Full Text] [Related]
40. Inhibitory actions of procaterol, a beta-2 stimulant, on substance P-induced cough in normal subjects during upper respiratory tract infection.
Katsumata U; Sekizawa K; Inoue H; Sasaki H; Takishima T
Tohoku J Exp Med; 1989 May; 158(1):105-6. PubMed ID: 2476867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
